Watch Ticker

Korro Bio, Inc. Common Stock

Go to Korro Bio, Inc. Common Stock Website

$15.31

-0.61 (-3.80%)

Live

Previous Close

$15.92

Day Range

$15.315 - $15.78

Previous Day Range

$15.02 - $16.02

Market Cap

$145.5 million USD

Day Vol.

4472

Previous Day Vol.

108717

Currency

USD

Primary Exchange

None

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency

Korro Bio, a clinical-stage biopharmaceutical company, announced that the FDA has granted orphan drug designation to its investigational medicine KRRO-110 for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). KRRO-110 is currently being evaluated in a Phase 1/2a clinical study, and the company expects to report interim data in the second half of 2025.

Related tickers: KRRO.

Read Full Article

Professor Ari Zoldan - 4 Biotech Stocks With AI, Machine Learning Prowess

The article discusses four biotech companies leveraging AI and machine learning technology to improve drug discovery and development processes. These companies are Absci, Firefly Neuroscience, Korro Bio, and NeuroSense Therapeutics.

Related tickers: ABSI, AIFF, KRRO, NRSN, NRSNW.

Read Full Article

Trending Tickers

Please sign in to view